These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5656869)

  • 21. Cryoprecipitate.
    Armstrong D
    S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of recombinant and plasma-derived factor VIII products in paediatric patients with severe haemophilia A.
    Steele MR; Nagel K; Chan AK
    Haemophilia; 2014 Jan; 20(1):e100-1. PubMed ID: 24251412
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemophilia in Somalia.
    Abdulle OA; Mohamud MS; Isse MM; Chistolini A; Papacchini M; Mariani G
    Haemostasis; 1989; 19(2):100-4. PubMed ID: 2499520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of factor 8 rich cryoproteins in the treatment of hemophilia].
    Vergoz D; Combrisson A; Vialette T; André R
    Transfusion (Paris); 1967; 10(1):3-10. PubMed ID: 6048649
    [No Abstract]   [Full Text] [Related]  

  • 25. Appendectomy in hemophilia with the use of cryoprecipitated human factor 8 to control bleeding.
    Schwartz JM; Cohn BD; Ritz ND; Levy T
    JAMA; 1966 Dec; 198(11):1175-9. PubMed ID: 5953498
    [No Abstract]   [Full Text] [Related]  

  • 26. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 27. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bleeding times in haemophilia patients treated with lyophilised antihaemophilic globulin (AHG) (author's transl)].
    Sutor AH; Jesdinsky-Buscher CJ
    Dtsch Med Wochenschr; 1976 Nov; 101(47):1715-9. PubMed ID: 991757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costing cryoprecipitate for haemophilia.
    Carter F; Macfarlane J; Forbes CD; Prentice CR; Wallace J
    Br Med J; 1975 May; 2(5965):256. PubMed ID: 1131577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bleeding in haemophilia during massive treatment with anti-haemophilic globulin (author's transl)].
    Sutor AH; Jesdinsky-Buscher C
    Dtsch Med Wochenschr; 1975 May; 100(21):1183-6. PubMed ID: 1132328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory and clinical evaluation of concentrates for treatment of haemophilia.
    Verstraete M; Vermylen J
    Acta Clin Belg; 1975; 30(5):437-48. PubMed ID: 1221749
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemophilia management in New Zealand: an Auckland perspective.
    Ockelford PA; Benny AG; Van de Water NS; Berry EW
    N Z Med J; 1989 Apr; 102(866):189-91. PubMed ID: 2496366
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A.
    Young JH; Liu HC; Hsueh EJ; Huang ML; Peng CT; Chen RL; Maas-Enriquez M; Achilles K
    Haemophilia; 2009 Jul; 15(4):968-70. PubMed ID: 19473407
    [No Abstract]   [Full Text] [Related]  

  • 34. A simple and inexpensive device for pooling cryoprecipitate.
    Low WT; Gillon R; Jones P
    Lancet; 1977 Sep; 2(8039):641. PubMed ID: 71453
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of haemophilia A with purified factor 8 obtained from human plasma by cryoprecipitation.
    Meyer K; Eernisse JG; Veltkamp JJ; Hemker HC; Loeliger EA
    Folia Med Neerl; 1967; 10(2):49-60. PubMed ID: 6039247
    [No Abstract]   [Full Text] [Related]  

  • 36. The laboratory assessment of the efficacy of antihaemophilic therapy.
    Lurie A
    S Afr Med J; 1972 Jun; 46(25):844. PubMed ID: 5076068
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of hemophilia with factor 8 concentrates.
    Dallman PR; Pool JG
    N Engl J Med; 1968 Jan; 278(4):199-202. PubMed ID: 5711341
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylaxis in children with haemophilia - the Polish experience.
    Klukowska A; Urasinski T; Janik-Moszant A; Bobrowska H; Balwierz W; Woznica-Karczmarz I; Dobaczewski G; Wlazlowski M; Koltan A; Badowska W; Dakowicz L; Karolczyk G; Kostrzewska M; Korczowski B; Wasinski D; Pietrys D; Laguna P; Wysocka M
    Haemophilia; 2014 Jan; 20(1):e108-10. PubMed ID: 24251651
    [No Abstract]   [Full Text] [Related]  

  • 39. Maintenance of treatment logs by haemophilia patients.
    du Treil S; Rice J; Leissinger CA
    Haemophilia; 2010 May; 16(3):545-7. PubMed ID: 20050930
    [No Abstract]   [Full Text] [Related]  

  • 40. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.